Abrahams, Timothy
Nelson, Adam J.
Nicholls, Stephen J.
Funding for this research was provided by:
Monash University
Article History
Accepted: 10 January 2024
First Online: 31 January 2024
Declarations
:
: S.J.N. has received research support from AstraZeneca, Amgen, Anthera, CSL Behring, Cerenis, Eli Lilly, Resverlogix, New Amsterdam Pharma, Novartis, InfraReDx and Sanofi-Regeneron. S.J.N. is also a consultant for Amgen, Akcea, AstraZeneca, Boehringer Ingelheim, CSL Behring, Eli Lilly, Esperion, Kowa, Merck, Takeda, Pfizer, Sanofi- Regeneron, Vaxxinity, CSL Sequiris, and Novo Nordisk. S.J.N. also reports grants and personal fees from Esperion. A.J.N. has received research support and consulting fees from Amgen and Novartis. T.A. has no relationships to disclose.
: This article does not contain any studies with human or animal subjects performed by any of the authors.